Iizuka, Toshiaki; Kubo, Kensuke - In: Health Economics, Policy and Law 6 (2011) 03, pp. 369-389
Historically, brand-name pharmaceuticals have enjoyed long periods of market exclusivity in Japan, given the limited use of generics after patent expiration. To improve the efficiency of the health-care system, however, the government has recently implemented various policies aimed at increasing...